Clinical-pathological characterization of laryngeal cancer in the Mexican population
Keywords:
Laryngeal Neoplasms, Mexico, PopulationAbstract
Background: Cancer of the larynx occupies the first frequency site of cancer of the upper digestive tract and represents 42% of malignant neoplasms of the upper aero-digestive tract. It is a potentially curable entity if it is diagnosed in early stages.
Objective: Characterize the clinical pathological features of patients with laryngeal cancer, which can serve as a guide for diagnostic suspicion in primary and secondary care.
Method: Descriptive study. All the records of patients with an initial diagnosis of primary laryngeal carcinoma undergoing direct micro-laryngoscopy plus biopsy from January 1, 2014 to December 31, 2018 were analyzed.
Results: 173 new cases of laryngeal carcinoma were diagnosed, the male sex predominated (86%). With an average age of presentation of 65 ± 11 years and a history of smoking in 78.6% (n 136). Dysphonia was the initial symptom in 81% (140) of the patients.
Conclusions: The profile of the patient with laryngeal cancer corresponds to a patient older than 60 years, male, a history of smoking and a history of dysphonia greater than 30 days. Clinically, we will find an epithelial epidermoid moderately differentiated tumor limited to the glottis.
Downloads
References
Flores Díaz R, Martínez Martínez G, Velázquez Chong H. Diagnóstico y tratamiento del carcinoma epidermoide de laringe. CENETEC; 2010. Disponible en: http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/471_GPC_CaLaringe/GER_CANCER_DE_LARINGE.pdf. Consultado el 8 Julio 2020
Granados M, Luna K, Campos E, Lavin A. Cáncer de la laringe: nuevas tendencias. Cancerología. 2007;2:55-66.
Dyckhoff G, Plinkert PK, Ramroth H. A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients. BMC Cancer. 2017;17(1):1-9.
García-Sánchez M, Romero-Durán E, Mantilla-Morales A, Gallegos-Hernández JF. Laringectomía subtotal supracricoidea. La importancia del análisis histopatológico. Gac Mex Oncol. 2014;13(3):167-71.
Francisco J, Stamerra L, Eman M. National consensus on larynx cancer diagnosis and treatment. Revista Venezolana de Oncologia. 2012;24(1):64-95.
Herrera-Gómez A, Villavicencio-Valencia V, Rascón-Ortiz M, Luna-Ortiz K. Demografía del cáncer laríngeo en el Instituto Nacional de Cancerología. Cir Cir. 2009;77(5):353-7.
Mohar-Betancourt A, Reynoso-Noverón N, Armas-Texta D, Gutiérrez-Delgado C, Torres-Domínguez JA. Cancer trends in Mexico: essential data for the creation and follow-up of public policies. J Glob Oncol. 2017;3(6):740-8. doi: 10.1200/JGO.2016.007476
Sierra M, Soerjomataram I, Antoni S, Laversanne M, Piñeros M, de Vries E, et al. Cancer patterns and trends in Central and South America. Cancer Epidemiol. 2016;44:S23-S42. doi: 10.1016/j.canep.2016.07.013
Aldaco-Sarvide F, Pérez-Pérez P, Cervantes-Sánchez G, Torrecillas-Torres L, Erazo-Valle-Solís A, Cabrera-Galeana P, et al. Mortalidad por cáncer en México: actualización 2015. Gac Mex Oncol. 2018;17:24-30. doi: 10.24875/j.gamo.M18000105
Ortega G, Cardemil F. Estimación de la incidencia del cáncer de laringe en Chile según la aplicación de un formulario de registro digital. Rev Otorrinolaringol Cir Cabeza Cuello. 2017;77(2):150-6. doi: 10.4067/S0718-48162017000200005.
International Agency for Research on Cancer (IARC), World Health Organization (WHO). Cancer today. Gco.iarc.fr.; 2020. Disponible en: https://gco.iarc.fr/today/fact-sheets-populations. Consultado el 8 Julio 2020.
Huerta AA, Rojo SA, Antonio J, Machado L. Frecuencia, aspectos clínicos y factores asociados al cáncer de laringe. Rev Otorrinolaringol Cir Cabeza Cuello. 2017;45(4):240-6.
Yang PC, Thomas DB, Daling JR, Davis S. Differences in the sex ratio of laryngeal cancer incidence rates by anatomic subsite. J Clin Epidemiol. 1989;42(8):755-8. doi: 10.1016/0895-4356(89)90072-3
Talamini R, Bosetti C, La Vecchia C, Dal Maso L, Levi F, Bidoli E, et al. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control. 2002;13(10):957-64. doi: 10.1023/a:1021944123914
Steuer CE, El-Deiry M, Parks JR, Higgins KA, Saba NF. An update on larynx cancer. CA Cancer J Clin. 2017;67(1):31-50. doi:10.3322/caac.21386
Ciolofan MS, Vlăescu AN, Mogoantă C-A, Ioniță E, Ioniță I, Căpitănescu A-N, et al. Clinical, histological and immunohistochemical evaluation of larynx cancer. Curr Health Sci J. 2017;43(4):367-75. doi: 10.12865/CHSJ.43.04.14
Jones TM, De M, Foran B, Harrington K, Mortimore S. Laryngeal cancer: United Kingdom National Multidisciplinary guidelines. J Laryngol Otol. 2016;130(S2):S75-82. doi: 10.1017/S0022215116000487
Markou K, Christoforidou A, Karasmanis I, Tsiropoulos G, Triaridis S, Constantinidis I, et al. Laryngeal cancer: epidemiological data from Northern Greece and review of the literature. Hippokratia. 2013;17(4):313-8.
Lim S, Sau P, Cooper L, McPhaden A, Mackenzie K. The incidence of premalignant and malignant disease in Reinke’s edema. Otolaryngol Head Neck Surg. 2014;150(3):434-6. doi: 10.1177/0194599813520123
Dogantemur S, Ozdemir S, Uguz A, Surmelioglu O, Dagkiran M, Tarkan O, et al. Assessment of HPV 16, HPV 18, p16 expression in advanced stage laryngeal cancer patients and prognostic significance. Braz J Otorhinolaryngol. 2020;86(3):351-7. doi:10.1016/j.bjorl.2019.11.005
Abdel Tawab H, Abd El Messih M, Al Naggar N, El Sharkawy L. Study of the epidemiology and management of laryngeal cancer in Kasr Al-Aini Hospital. Egypt J Otolaryngol. 2014;30(3):208. doi: 10.4103/1012-5574.138468
Downloads
Published
Issue
Section
License
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.
